In addition, our results showed that the truncated variant S3, which contains only a single ABD domain and a C-terminal IGcam domain, was sufficient to sustain the normal function of the Nexilin protein, which may provide an alternative option of Nexilin gene therapy for the treatment of DCM. The gene discussed is NEXN; the disease is familial dilated cardiomyopathy.